Skip to main content
OpenTrials
Completed

NCT Number: NCT02984306

Effect of Cherry Powder Supplementation on Vascular Function

Examining the effect of four weeks of cherry powder supplementation on flow mediated dilatation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

40 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Sport & Health Sciences

Exeter, Devon, EX1 2LU, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • physically inactive no prescription medications

Exclusion criteria

  • physically active taking prescription medication

Treatment and study plan

Cherry powder

Dietary Supplement

Placebo

Dietary Supplement

Primary outcomes

  1. Flow mediated dilatation

    Time frame: change from baseline to 4 weeks dietary supplementation

Secondary outcomes

  1. Plasma nitrite concentration

    Time frame: change from baseline to 4 weeks dietary supplementation

  2. Plasma nitrate concentration

    Time frame: change from baseline to 4 weeks dietary supplementation

Sponsors and collaborators

Lead sponsor

University of Exeter

Other

Registry information

Important dates

Study start
2012
Primary completion
2016
Study completion
2016
First posted
Dec 6, 2016
Registry last updated
Dec 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.